Skip to main content

HealthTimes

Health News

Zim targets 4.2 million children in emergency polio vaccination

Michael Gwarisa

By Kudakwashe Pembere Having detected some cases of vaccine-derived poliovirus type 2 (cVDPV) in Harare, another has been identified in Sanyati, a district in Mashonaland West prompting Zimbabwe’s health authorities to activate an emergency vaccination campaign for children below 10 years of age this month. The vaccination blitz intends to vaccinate 4.2 million children across

Read More
jonson
Global Health

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial

Michael Gwarisa

Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468

Read More